Equity avatar

Dexa/Equity

Learn more
Published Mar 26, 2021

You can only invest if you promise not to read the fine print, ok?

Explore the evolving landscape of venture capital in the wake of high-profile controversies such as David Dobrik's exit from Dispo, the rapid dynamics of startup funding spotlighted by Plaid and Bevy's investments, and innovative shifts in health care models including cash-based systems and advancements in women's health.
Episode Highlights
Equity logo

Topics covered

Popular Clips

Episode Highlights

  • VC Dynamics

    The relationship between VCs and startups is increasingly influenced by the need for rapid decision-making and thorough due diligence. and discuss how the pressure to quickly invest in hot deals often leads to insufficient vetting of founders, as seen with Dispo and David Dobrik 1. highlights the dilemma VCs face, where failing to close deals quickly can damage their reputation in the industry 2.

    You still have this 30-day window, right? Like, I don't think VCs have negotiated away their due diligence windows. But, you know, if you don't close, then you become known as the VC who doesn't close on a round.

    ---

    This accelerated pace creates a collective action problem, where the fear of missing out (FOMO) drives VCs to make hasty decisions 2.

       

    Influencer Impact

    The rise of influencer-driven startups adds another layer of complexity to VC dynamics. notes that VCs often accept that a portion of their investments may turn out to be frauds, as the pressure to invest quickly outweighs the risks 3. This trend is exemplified by the challenges in unwinding early-stage investments when controversies arise, as seen with Dispo 4.

    The challenge for a lot of VC firms, it's very hard to unwind an early-stage investment. The only way you can do that is everyone around the cap table has to agree legally to allow you to extricate yourself.

    ---

    This situation underscores the need for a more robust playbook to handle such scenarios in the future 3.

       

    Plaid's Position

    Highlighted funding rounds reveal significant financial movements and strategic decisions. and discuss Plaid's potential $600 million raise at a valuation between $10 billion and $15 billion, reflecting its strong market position despite regulatory challenges 5. emphasizes Plaid's dependence on bank data and the risks involved 6.

    Plaid independently is a tricky place to be. They just signed up 1400 customers last year, 4000 total. But at the end of the day, they are built on top of pulling information from other places, and those places don't want to give them that information increasingly, year after year.

    ---

    This situation highlights the delicate balance Plaid must maintain to continue its growth 6.

       

    Funding Rounds

    Bevy and Ro's recent funding rounds illustrate the industry's evolving landscape. highlights Bevy's $40 million Series C round, which notably included 20% investment from Black investors, reflecting a growing trend towards diversity in venture capital 7. discusses Ro's $500 million Series D round, showcasing its expansion from erectile dysfunction treatments to a broader range of health services 8.

    Roe has raised 500 million in a series D round. It focused on erectile dysfunction drugs and specifically a single drug that came out of path. It was generic, and they popularized sort of a direct-to-consumer health model that we haven't really seen much.

    ---

    These rounds underscore the significant financial commitments and strategic shifts within the industry 8.

Related Episodes